Loading…
DarioHealth Corp. is projected to rise to $7.41 by 2027, a +2% move from its current price of $7.27. DRIO is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $7.00 | $7.27 | $7.54 | -0.02% |
| Aug 6 | $6.90 | $7.27 | $7.66 | -0.04% |
| Aug 7 | $6.81 | $7.27 | $7.75 | -0.06% |
| Aug 8 | $6.75 | $7.26 | $7.82 | -0.08% |
| Aug 9 | $6.69 | $7.26 | $7.89 | -0.10% |
| Aug 10 | $6.63 | $7.26 | $7.95 | -0.11% |
| Aug 11 | $6.58 | $7.26 | $8.01 | -0.13% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $6.58 | $7.26 | $8.01 | -0.13% |
| Week 2 | $6.31 | $7.25 | $8.33 | -0.27% |
| Week 3 | $6.11 | $7.24 | $8.58 | -0.40% |
| Week 4 | $5.94 | $7.23 | $8.80 | -0.53% |
| Week 5 | $5.80 | $7.22 | $8.99 | -0.67% |
| Week 6 | $5.67 | $7.21 | $9.17 | -0.80% |
| Week 7 | $5.56 | $7.20 | $9.34 | -0.93% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
DarioHealth Corp. (DRIO) is a healthcare company that operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the symptoms of stress, anxiety, and depression; Dario Move, focuses on improving posture to alleviate pain with medical device; and Dario Health, a self-care application and virtual coaching platform for diabetes, hypertension, and weight management and GLP-1. It also provides bundled full-suite or partial-suite subscriptions. The company was formerly known as LabStyle Innovations Corp.
and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
DarioHealth Corp. is currently priced at $7.10 per share and trades within the healthcare sector. The company has a market cap of $69.22M and ranks 4378 by market cap.
Forecasts show a near-term neutral path with upside potential in the coming years. For 2026, the avg price is $7.10 (min $5.99, max $9.37); 2027 shows an avg of $7.02 (min $5.37, max $9.81); 2028 an avg of $6.79 (min $4.99, max $9.99); 2029 an avg of $9.23 (min $6.54, max $14.11) with bullish momentum continuing into 2030 (avg $10.48, max $16.56) and beyond, culminating in a 2050 avg of $30.75 (max $66.01). ROI figures accompany several years, with 2029 at 29.9%, 2030 at 47.6%, 2031 at 42.6%, 2032 at 48%, 2033 at 34.5%, 2034 at 46.8%, 2035 at 89.3%, 2040 at 109.7%, and 2050 at 333.1%.
Sentiment shifts from NEUTRAL in the near term to BULLISH in later years, reflecting an overall positive longer-term outlook despite some earlier uncertainty.
A major floor 29.3% below — a decisive break under it would weaken the trend.
The nearest floor, 17.6% below — buyers have tended to step in here.
The nearest ceiling, 8.7% above — a clean break opens room to run.
A major ceiling 23.3% above — clearing it would confirm fresh momentum.
Key DRIO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of DRIO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $7.31 | Sell | $7.29 | Sell |
| MA 10 | $7.35 | Sell | $7.27 | Buy |
| MA 20 | $7.14 | Buy | $7.18 | Buy |
| MA 50 | $7.17 | Buy | $7.28 | Sell |
| MA 100 | $7.52 | Sell | $7.90 | Sell |
| MA 200 | $9.77 | Sell | $9.33 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 51.64 | Neutral |
| Stoch RSI (14) | 44.85 | Neutral |
| CCI (20) | 31.41 | Neutral |
| Williams %R (14) | -45.99 | Info |
| MACD (12,26,9) | 0.03 | Buy |
| ROC (12) | 7.70 | Buy |
| Bollinger %B (20,2) | 0.59 | Neutral |
| Stochastic %K (14) | 54.01 | Neutral |
| TRIX (15) | 0.10 | Buy |
| Awesome (5,34) | 0.33 | Buy |
| Ultimate (7,14,28) | 42.57 | Neutral |
| Momentum (10) | 0.46 | Buy |
| Aroon Osc (25) | 72.00 | Buy |
| Hull MA (9) | 7.15 | Buy |
| ADX (14) | 10.66 | Neutral |
| ATR (14) | 0.24 | Info |
Near-term technical picture is NEUTRAL. The RSI(14) is 50, with the 50-day simple moving average at $7.21 and the 200-day simple moving average at $9.85.
Key levels include a support at $5.99 and a resistance at $7.90. The 30-day price range spans from $5.48 up to $9.19, indicating a broad trading band in the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $5.99 | $7.27 | $9.61 | 0% | Neutral | |
| $5.72 | $7.41 | $10.26 | +2% | Neutral | |
| $5.40 | $7.28 | $10.58 | 0% | Neutral | |
| $7.16 | $9.98 | $15.06 | +37% | Bullish | |
| $7.85 | $11.26 | $17.54 | +55% | Bullish | |
| $7.40 | $10.92 | $17.46 | +50% | Bullish | |
| $7.59 | $11.49 | $18.83 | +58% | Bullish | |
| $6.82 | $10.58 | $17.71 | +45% | Bullish | |
| $7.34 | $11.65 | $19.89 | +60% | Bullish | |
| $9.35 | $15.17 | $26.39 | +109% | Bullish | |
| $9.47 | $17.02 | $31.94 | +134% | Bullish | |
| $16.38 | $35.47 | $74.24 | +388% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $5.99 | $7.27 | $9.07 | +0.00% |
| September 2026 | $6.17 | $7.37 | $9.11 | +1.36% |
| October 2026 | $5.92 | $7.14 | $8.96 | -3.05% |
| November 2026 | $6.05 | $7.35 | $9.32 | +2.90% |
| December 2026 | $6.13 | $7.50 | $9.61 | +2.06% |
Click any year to see its month-by-month DRIO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
DarioHealth Corp.'s 2026 outlook centres on $7.27, within a $5.99 to $9.61 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, DRIO could reach as high as $10.26, with a base case around $7.41 and support toward $5.72 — roughly +2% from $7.27. Price action looks broadly range-bound.
Expect DRIO to range from $5.40 to $10.58 through 2028. The $7.28 average target implies a 0% move from current prices. That is -2% versus the projected 2027 average. A consolidation phase looks the most probable path here.
The DRIO price prediction for 2029 points to an average of $9.98 (low $7.16, high $15.06) — a potential gain of +37% on today's $7.27. Momentum favours further upside here.
In 2030, DRIO is projected to trade between $7.85 and $17.54, averaging $11.26 — a potential gain of +55% from today's $7.27. That is up +13% on the projected 2029 average. Buyers look set to stay in control over this stretch.
DarioHealth Corp.'s 2031 outlook centres on $10.92, within a $7.40 to $17.46 range. That is -3% versus the projected 2030 average. That marks a +50% change versus current levels. Momentum favours further upside here.
By 2032, DRIO could reach as high as $18.83, with a base case around $11.49 and support toward $7.59 — roughly +58% from $7.27. Buyers look set to stay in control over this stretch.
Expect DRIO to range from $6.82 to $17.71 through 2033. The $10.58 average target implies a +45% move from current prices. That is -8% versus the projected 2032 average. Momentum favours further upside here.
The DRIO price prediction for 2034 points to an average of $11.65 (low $7.34, high $19.89) — a potential gain of +60% on today's $7.27. Buyers look set to stay in control over this stretch.
In 2035, DRIO is projected to trade between $9.35 and $26.39, averaging $15.17 — a potential gain of +109% from today's $7.27. That is up +30% on the projected 2034 average. Momentum favours further upside here.
DarioHealth Corp.'s 2040 outlook centres on $17.02, within a $9.47 to $31.94 range. That is up +12% on the projected 2035 average. That marks a +134% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, DRIO could reach as high as $74.24, with a base case around $35.47 and support toward $16.38 — roughly +388% from $7.27. Momentum favours further upside here.
Investing $1,000 in DRIO today (≈ 137.551582 DRIO) could be worth
$4,879.01
+$3,879.01 (+388%) by 2050 · US Dollar
Based on the average projected DRIO price of $35.47 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in DRIOwould be worth at today's price.
$1,000 invested in DRIO on Jul 31, 2025 (≈ 87.260035 DRIO) would be worth
$634.38
-$365.62 (-36.6%) today · 0.63× · US Dollar
Based on a DRIO entry price of $11.46 vs. today's $7.27.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $7.79 | $933.25 | -6.7% |
| 1 month ago | $6.75 | $1,077.04 | +7.7% |
| 3 months ago | $7.3 | $995.89 | -0.4% |
| 6 months ago | $10.94 | $664.53 | -33.5% |
| 1 year ago | $11.46 | $634.38 | -36.6% |
| All time (5.0y) ago | $293.6 | $24.76 | -97.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our DRIO forecast.
Our base-case forecast reaches $15.00 around 2035.
Implied market cap at $15.00: $146.24M
The multi-year forecast points to a bullish tilt starting in 2029 and continuing through 2050, with notable upside in several years. In 2029 the avg price is $9.23 and the max is $14.11, with a projected ROI of 29.9% and a bullish sentiment. By 2030 the avg price is $10.48 with a max of $16.56, and ROI of 47.6%, maintaining a bullish stance.
Further out, 2031 shows an avg of $10.13 and 2032 $10.51, both with bullish sentiment and potential upside, while 2035 carries a strong 89.3% ROI with an avg of $13.44 and max $23.83. The 2040 forecast projects an avg of $14.89 and max $28.56 (ROI 109.7%), culminating in 2050 with an avg of $30.75 and max $66.01 and a 333.1% ROI. Across 2026–2050, sentiment progresses from NEUTRAL to BULLISH, reflecting an evolving upside trajectory alongside higher potential returns, but the forecasts are not guaranteed and carry inherent uncertainty.
The asset also shows high volatility, as indicated by an annualized volatility of 70%.
Tap a question to reveal the answer.
The forecast for 2030 shows an avg price of $10.48 with a min of $7.19 and a max of $16.56, and a projected ROI of 47.6% with a BULLISH sentiment.
Forecasts indicate NEUTRAL sentiment in the near term and BULLISH sentiment from 2029 onward, with significant upside by 2050 (avg $30.75, max $66.01) and ROI up to 333.1%, though early years show more modest gains and higher uncertainty.
Yes.
The current price is $7.10 and the market cap is $69.22M.
The 30-day range is $5.48 to $9.19.
DarioHealth Corp. Community Discussion
0Share your DarioHealth Corp. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.